Sequence identification, chromosomal mapping and tissue specific expression of the porcine paraoxonase 1 (PON1) gene

Molecular Biology Reports

Volumn 37, Issue 3, 2010, Pages 1347-1353

  Xie, Shuihua ^a   Li, Jiaqi ^a   Chen, Yaosheng ^b   Wang, Chong ^a   Zhang, Hao ^a   Mo, Delin ^b  

^a SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Bacterial artificial chromosome; Mapping; Pig; Real time PCR; Serum paraoxonase

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; COMPLEMENTARY DNA; GENOMIC DNA; ARYLDIALKYLPHOSPHATASE;

AMINO ACID COMPOSITION; ANIMAL GENETICS; ANIMAL TISSUE; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CHROMOSOME 9; CHROMOSOME MAP; CONTROLLED STUDY; DNA SEQUENCE; EXON; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCATION; INTRON; MICROSATELLITE MARKER; MOLECULAR CLONING; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SPECIES COMPARISON; SWINE; TISSUE DISTRIBUTION; TISSUE SPECIFICITY; AMINO ACID SEQUENCE; ANIMAL; ANTIBODY SPECIFICITY; GENE STRUCTURE; GENETICS; METABOLISM; MOLECULAR GENETICS; VISCERA;

BACTERIA (MICROORGANISMS); SUIDAE; SUS;

AMINO ACID SEQUENCE; ANIMALS; ARYLDIALKYLPHOSPHATASE; BASE SEQUENCE; CHROMOSOME MAPPING; DNA, COMPLEMENTARY; GENE COMPONENTS; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; SEQUENCE ANALYSIS, DNA; SUS SCROFA; VISCERA;

EID: 77951885320     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-009-9514-6     Document Type: Article

References (27)

1. Primo-Parmo SL, Sorenson RC, Teiber J et al (1996) The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 33:498-507. doi:10.1006/geno.1996. 0225
2. Mackness MI, Arrol S, Abbott C et al (1991) Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett 286:152-154. doi:10.1016/0014-5793(91)80962-3
3. Watson AD, Berliner JA, Hama SY et al (1995) Protective effect of high-density lipoprotein associated PON. Inhibition of biological activity of minimally oxidized low density lipoprotein. J Clin Invest 96:2882-2891. doi:10.1172/JCI118359
4. Aviram M, Rosenblat M, Bisgaier CL et al (1998) Paraoxonase inhibits high-density lipoprotein oxidation and preserves its function. A possible peroxidative role for paraoxonase. J Clin Invest 101:1581-1590. doi:10.1172/JCI1649
5. Rodrigo L, Mackness B, Durrington PI et al (2001) Hydrolysis of platelet-activating factor by human serum paraoxonase. Biochem J 354:1-7. doi:10.1042/0264-6021:3540001
6. Ng CJ, Shiha DM, Hamaa SY et al (2005) The paraoxonase gene family and atherosclerosis. Free Radic Biol Med 38:153-163. doi:10.1016/j.freeradbiomed. 2004.09.035
7. Hillier LW, Fulton RS, Fulton LA et al (2003) The DNA sequence of human chromosome 7. Nature 424:157-164. doi: 10.1038/nature01782
8. Hassett C, Richter RJ, Humbert R et al (1991) Characterization of cDNA clones encoding rabbit and human serum paraoxonase: The mature protein retains its signal sequence. Biochemistry 30:10141-10149. doi:10.1021/bi00106a010
9. Adkins S, Gan KN, Modyt M et al (1993) Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: Glutamine or arginine at position 191, for the respective A or B allozymes. Am J Hum Genet 52:598-608
10. Leviev I, James RW (2000) Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations. Arterioscler Thromb Vasc Biol 20:516-521
11. Lusis AJ (2000) Atherosclerosis. Nature 407:233-241. doi: 10.1038/35025203
12. Draganov DI, La Du BN (2004) Pharmacogenetics of paraoxonases: A brief review. Naunyn Schmiedebergs Arch Pharmacol 369:78-88. doi:10.1007/s00210-003- 0833-1
13. Paragh G, Seres I, Balogh Z et al (1998) The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia. Nephron 80:166-170. doi:10.1159/000045161
14. Mackness B, Mackness MI, Durrington PN et al (2000) Paraoxonase activity in two healthy populations with differing rates of coronary heart disease. Eur J Clin Invest 30:4-10. doi:10.1046/ j.1365-2362.2000.00580.x
15. Mackness B, Mackness MI, Arrol S et al (1998) Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus. Atherosclerosis 139:341-349. doi:10.1016/S0021-9150 (98)00095-1
16. Mackness B, Durrington PN, Boulton AJ et al (2002) Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls. Eur J Clin Invest 32:259-264. doi:10.1046/ j.1365-2362.2002.00977.x
17. Tanimoto N, Kumon Y, Suehiro T et al (2003) Serum paraoxonase activity decreases in rheumatoid arthritis. Life Sci 72:2877-2885. doi:10.1016/S0024- 3205(03)00195-4
18. Senti M, Tomas M, Fito M et al (2003) Antioxidant paraoxonase 1 activity in the metabolic syndrome. J Clin Endocrinol Metab 88:5422-5426. doi:10.1210/jc.2003-030648
19. Liu W, Zhang Y, Liu Z et al (2006) A five-fold pig bacterial artificial chromosome library: A resource for positional cloning and physical mapping. Prog Nat Sci 16:889-892. doi:10.1080/ 10020070612331343207
20. Yerle M, Pinton P, Robic A et al (1998) Construction of a whole genome radiation hybrid panel for high-resolution gene mapping in pigs. Cytogenet Cell Genet 82:182-188. doi:10.1159/0000 15095
21. International Human Genome Sequencing Consortium (2004) Finishing the euchromatic sequence of the human genome. Nature 431:931-945. doi:10.1038/nature03001
22. Waterston RH, Lindblad-Toh K, Birney E et al (2002) Initial sequencing and comparative analysis of the mouse genome. Nature 420:520-562. doi:10.1038/nature01262
23. Humbert R, Adler DA, Disteche CM et al (1993) The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 3:73-76. doi:10.1038/ng0193-73
24. Goureau A, Yerle M, Schmitz A et al (1996) Human and porcine correspondence of chromosome segments using bidirectional chromosome painting. Genomics 36:252-262. doi:10.1006/geno. 1996.0460
25. Kelso GJ, Stuart WD, Richter RJ et al (1994) Apolipoprotein J is associated with paraoxonase in human plasma. Biochemistry 33:832-839. doi:10.1021/bi00169a026
26. Dantoine TF, Debord J, Charmes JP et al (1998) Decrease of serum paraoxonase activity in chronic renal failure. J Am Soc Nephrol 9:2082-2088
27. Biasioli S, Schiavon R, Petrosino L et al (2003) Paraoxonase activity and paraoxonase 1 gene polymorphism in patients with uremia. ASAIO J 49:295-299. doi:10.1097/01.MAT.0000066256. 19852.29